Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,130 | 66,610 | 52,032 | 47,105 | 27,147 |
| Marketable Securities | 3,007 | 26,050 | 56,053 | 72,590 | 104,130 |
| Receivables | 1,104 | 1,563 | 740 | 878 | 915 |
| TOTAL | $103,241 | $94,223 | $108,825 | $120,573 | $132,192 |
| Non-Current Assets | |||||
| PPE Net | 781 | 849 | 905 | 1,029 | 1,092 |
| Other Non-Current Assets | 404 | 551 | 599 | 0 | 0 |
| TOTAL | $1,185 | $1,400 | $1,504 | $1,029 | $1,092 |
| Total Assets | $104,426 | $95,623 | $110,329 | $121,602 | $133,284 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,348 | 9,355 | 10,956 | 6,997 | 8,128 |
| TOTAL | $13,348 | $9,355 | $10,956 | $6,997 | $8,128 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 401 | 443 | 486 | 513 | 548 |
| TOTAL | $401 | $443 | $486 | $513 | $548 |
| Total Liabilities | $13,749 | $9,798 | $11,442 | $7,510 | $8,676 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,177 | 1,175 | 1,175 | 1,173 | 1,173 |
| Retained earnings | -210,207 | -213,125 | -198,502 | -182,234 | -170,401 |
| Other shareholders' equity | -2 | -24 | -70 | -103 | -205 |
| TOTAL | $90,677 | $85,825 | $98,887 | $114,092 | $124,608 |
| Total Liabilities And Equity | $104,426 | $95,623 | $110,329 | $121,602 | $133,284 |